high definition diagnostics℠

Technology Designed to Reveal More

Simoa's revolutionary digital approach to immunoassays allows single molecules to be counted, delivering a roughly 1000-fold increase in sensitivity. This remarkable sensitivity combined with full automation unlocks a world of insight into disease detection, diagnosis, and patient treatment while meeting the demands of today's laboratory.

 

Watch the Simoa video to learn more

 
 

Unprecedented Sensitivity

1000 times greater sensitivity than conventional immunoassays.
Learn More.

 

Robust Multiplexing

Improve efficiencies and stretch samples with up to 10-plex assays.
Learn More.

 

Complete Automation

Sample in, result out with an intuitive, user-friendly interface.
Learn More.

 

Quanterix News

  • AAPS National Biotechnology 2015

    San Francisco, CA
    June 8-10, 2015
    Booth #408

    Registration at www.aaps.org/nationalbiotech

  • Biomarkers & Diagnostics World Congress 2015

    Philadelphia, PA
    May 5-7, 2015
    Booth #17

    Registration at www.biomarkerworldcongress.com

    • Presentation: Ultrasensitive Multiplexed Cytokine Measurements
      Speaker: Mark Roskey, Ph.D., VP/GM, Applications and Reagents, Quanterix
      Date: Tuesday, May 5, 2015
  • Quanterix’ Simoa Technology to Broaden RayBiotech Immunoassay Services

    LEXINGTON, MA – March 31, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that RayBiotech, Inc., of Norcross, GA, has adopted its Simoa technology to deploy as part of their innovative solutions for biomarker discovery and testing.